Annual Long Term Debt
$1.26 B
-$14.40 M-1.13%
31 December 2023
Summary:
Alnylam Pharmaceuticals annual long term debt is currently $1.26 billion, with the most recent change of -$14.40 million (-1.13%) on 31 December 2023. During the last 3 years, it has risen by +$779.56 million (+160.96%). ALNY annual long term debt is now -1.13% below its all-time high of $1.28 billion, reached on 31 December 2022.ALNY Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$1.26 B
-$2.36 M-0.19%
30 September 2024
Summary:
Alnylam Pharmaceuticals quarterly long term debt is currently $1.26 billion, with the most recent change of -$2.36 million (-0.19%) on 30 September 2024. Over the past year, it has dropped by -$7.84 million (-0.62%). ALNY quarterly long term debt is now -1.76% below its all-time high of $1.28 billion, reached on 30 September 2022.ALNY Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALNY Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -1.1% | -0.6% |
| 3 y3 years | +161.0% | +75.0% |
| 5 y5 years | +4112.9% | +355.6% |
ALNY Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -1.1% | +161.0% | -1.8% | +75.0% |
| 5 y | 5 years | -1.1% | +4112.9% | -1.8% | +356.8% |
| alltime | all time | -1.1% | >+9999.0% | -1.8% | >+9999.0% |
Alnylam Pharmaceuticals Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.26 B(-0.2%) |
| June 2024 | - | $1.26 B(+0.2%) |
| Mar 2024 | - | $1.26 B(-0.3%) |
| Dec 2023 | $1.26 B(-1.1%) | $1.26 B(-0.3%) |
| Sept 2023 | - | $1.27 B(-0.4%) |
| June 2023 | - | $1.27 B(-0.4%) |
| Mar 2023 | - | $1.28 B(-0.1%) |
| Dec 2022 | $1.28 B(+33.6%) | $1.28 B(-0.3%) |
| Sept 2022 | - | $1.28 B(+35.0%) |
| June 2022 | - | $949.74 M(-0.5%) |
| Mar 2022 | - | $954.10 M(-0.3%) |
| Dec 2021 | $957.04 M(+97.6%) | $957.04 M(+33.0%) |
| Sept 2021 | - | $719.83 M(-0.3%) |
| June 2021 | - | $721.71 M(+50.5%) |
| Mar 2021 | - | $479.61 M(-1.0%) |
| Dec 2020 | $484.32 M(+75.4%) | $484.32 M(+62.9%) |
| Sept 2020 | - | $297.26 M(+5.6%) |
| June 2020 | - | $281.62 M(+2.1%) |
| Mar 2020 | - | $275.78 M(-0.1%) |
| Dec 2019 | $276.13 M(+820.4%) | $276.13 M(-0.1%) |
| Sept 2019 | - | $276.46 M(-10.0%) |
| June 2019 | - | $307.21 M(-1.6%) |
| Mar 2019 | - | $312.30 M(+941.0%) |
| Dec 2018 | $30.00 M(0.0%) | $30.00 M(0.0%) |
| Sept 2018 | - | $30.00 M(0.0%) |
| June 2018 | - | $30.00 M(0.0%) |
| Mar 2018 | - | $30.00 M(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | $30.00 M(-80.0%) | $30.00 M(-80.0%) |
| Sept 2017 | - | $150.00 M(0.0%) |
| June 2017 | - | $150.00 M(0.0%) |
| Mar 2017 | - | $150.00 M(0.0%) |
| Dec 2016 | $150.00 M(+4962.4%) | $150.00 M(0.0%) |
| Sept 2016 | - | $150.00 M(0.0%) |
| June 2016 | - | $150.00 M(>+9900.0%) |
| Sept 2008 | - | $719.00 K(-23.3%) |
| June 2008 | - | $938.00 K(-52.0%) |
| Mar 2008 | - | $1.96 M(-34.0%) |
| Dec 2007 | $2.96 M(-49.9%) | $2.96 M(-24.9%) |
| Sept 2007 | - | $3.95 M(-19.6%) |
| June 2007 | - | $4.91 M(-3.1%) |
| Mar 2007 | - | $5.07 M(-14.4%) |
| Dec 2006 | $5.92 M(+7.2%) | $5.92 M(-8.0%) |
| Sept 2006 | - | $6.44 M(+1.6%) |
| June 2006 | - | $6.33 M(+19.1%) |
| Mar 2006 | - | $5.32 M(-3.6%) |
| Dec 2005 | $5.52 M(-13.9%) | $5.52 M(-4.5%) |
| Sept 2005 | - | $5.78 M(-6.5%) |
| June 2005 | - | $6.19 M(-4.5%) |
| Mar 2005 | - | $6.48 M(+1.0%) |
| Dec 2004 | $6.41 M(+392.8%) | $6.41 M(-2.7%) |
| Sept 2004 | - | $6.59 M(+15.5%) |
| June 2004 | - | $5.71 M(+203.6%) |
| Mar 2004 | - | $1.88 M(+44.4%) |
| Dec 2003 | $1.30 M | $1.30 M |
FAQ
- What is Alnylam Pharmaceuticals annual long term debt?
- What is the all time high annual long term debt for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals annual long term debt year-on-year change?
- What is Alnylam Pharmaceuticals quarterly long term debt?
- What is the all time high quarterly long term debt for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals quarterly long term debt year-on-year change?
What is Alnylam Pharmaceuticals annual long term debt?
The current annual long term debt of ALNY is $1.26 B
What is the all time high annual long term debt for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high annual long term debt is $1.28 B
What is Alnylam Pharmaceuticals annual long term debt year-on-year change?
Over the past year, ALNY annual long term debt has changed by -$14.40 M (-1.13%)
What is Alnylam Pharmaceuticals quarterly long term debt?
The current quarterly long term debt of ALNY is $1.26 B
What is the all time high quarterly long term debt for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high quarterly long term debt is $1.28 B
What is Alnylam Pharmaceuticals quarterly long term debt year-on-year change?
Over the past year, ALNY quarterly long term debt has changed by -$7.84 M (-0.62%)